These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 26485709

  • 1. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells.
    Acikgoz E, Guven U, Duzagac F, Uslu R, Kara M, Soner BC, Oktem G.
    PLoS One; 2015; 10(10):e0141090. PubMed ID: 26485709
    [Abstract] [Full Text] [Related]

  • 2. Phenethyl isothiocyanate (PEITC) promotes G2/M phase arrest via p53 expression and induces apoptosis through caspase- and mitochondria-dependent signaling pathways in human prostate cancer DU 145 cells.
    Tang NY, Huang YT, Yu CS, Ko YC, Wu SH, Ji BC, Yang JS, Yang JL, Hsia TC, Chen YY, Chung JG.
    Anticancer Res; 2011 May; 31(5):1691-702. PubMed ID: 21617228
    [Abstract] [Full Text] [Related]

  • 3. A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells.
    Atmaca H, Bozkurt E, Uzunoglu S, Uslu R, Karaca B.
    Toxicol Lett; 2013 Aug 14; 221(2):128-36. PubMed ID: 23792433
    [Abstract] [Full Text] [Related]

  • 4. Anti-angiogenic effects of trabectedin (Yondelis; ET-743) on human breast cancer cells.
    Atmaca H, Uzunoglu S.
    Eur Cytokine Netw; 2014 Mar 01; 25(1):1-7. PubMed ID: 24941346
    [Abstract] [Full Text] [Related]

  • 5. In vitro radiosensitisation by trabectedin in human cancer cell lines.
    Romero J, Zapata I, Córdoba S, Jimeno JM, López-Martín JA, Tercero JC, De La Torre A, Vargas JA, Molerón R, Sánchez-Prieto R.
    Eur J Cancer; 2008 Aug 01; 44(12):1726-33. PubMed ID: 18501589
    [Abstract] [Full Text] [Related]

  • 6. Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol.
    Soner BC, Aktug H, Acikgoz E, Duzagac F, Guven U, Ayla S, Cal C, Oktem G.
    Int J Mol Med; 2014 Nov 01; 34(5):1249-56. PubMed ID: 25216351
    [Abstract] [Full Text] [Related]

  • 7. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
    Suy S, Mitchell JB, Samuni A, Mueller S, Kasid U.
    Cancer; 2005 Mar 15; 103(6):1302-13. PubMed ID: 15685617
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng.
    Kamalidehghan B, Ghafouri-Fard S, Motevaseli E, Ahmadipour F.
    Drug Des Devel Ther; 2018 Mar 15; 12():1119-1133. PubMed ID: 29765202
    [Abstract] [Full Text] [Related]

  • 9. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
    Wong HC, Wong CC, Sagineedu SR, Loke SC, Lajis NH, Stanslas J.
    Cell Biol Toxicol; 2014 Oct 15; 30(5):269-88. PubMed ID: 25070834
    [Abstract] [Full Text] [Related]

  • 10. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3.
    Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ, Wang PS.
    J Cell Biochem; 2007 May 01; 101(1):44-56. PubMed ID: 17340628
    [Abstract] [Full Text] [Related]

  • 11. 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.
    Qadan LR, Perez-Stable CM, Anderson C, D'Ippolito G, Herron A, Howard GA, Roos BA.
    Biochem Biophys Res Commun; 2001 Aug 03; 285(5):1259-66. PubMed ID: 11478793
    [Abstract] [Full Text] [Related]

  • 12. Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair.
    Harnicek D, Kampmann E, Lauber K, Hennel R, Cardoso Martins AS, Guo Y, Belka C, Mörtl S, Gallmeier E, Kanaar R, Mansmann U, Hucl T, Lindner LH, Hiddemann W, Issels RD.
    Int J Cancer; 2016 Jul 15; 139(2):467-79. PubMed ID: 26933761
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach.
    Tavecchio M, Natoli C, Ubezio P, Erba E, D'Incalci M.
    Cell Prolif; 2007 Dec 15; 40(6):885-904. PubMed ID: 18021177
    [Abstract] [Full Text] [Related]

  • 14. Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma.
    Schöffski P, Wolter P, Clement P, Sciot R, De Wever I, Wozniak A, Stefan C, Dumez H.
    Future Oncol; 2007 Aug 15; 3(4):381-92. PubMed ID: 17661712
    [Abstract] [Full Text] [Related]

  • 15. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH.
    Int J Oncol; 2003 Apr 15; 22(4):787-94. PubMed ID: 12632069
    [Abstract] [Full Text] [Related]

  • 16. Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis.
    Rouhrazi H, Turgan N, Oktem G.
    Biotech Histochem; 2018 Apr 15; 93(2):77-88. PubMed ID: 29300112
    [Abstract] [Full Text] [Related]

  • 17. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
    El-Merahbi R, Liu YN, Eid A, Daoud G, Hosry L, Monzer A, Mouhieddine TH, Hamade A, Najjar F, Abou-Kheir W.
    PLoS One; 2014 Apr 15; 9(11):e112453. PubMed ID: 25380390
    [Abstract] [Full Text] [Related]

  • 18. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
    Hoda MA, Pirker C, Dong Y, Schelch K, Heffeter P, Kryeziu K, van Schoonhoven S, Klikovits T, Laszlo V, Rozsas A, Ozsvar J, Klepetko W, Döme B, Grusch M, Hegedüs B, Berger W.
    Mol Cancer Ther; 2016 Oct 15; 15(10):2357-2369. PubMed ID: 27512118
    [Abstract] [Full Text] [Related]

  • 19. Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: new molecular insight into the mechanism of action.
    Martínez-Serra J, Maffiotte E, Martín J, Bex T, Navarro-Palou M, Ros T, Plazas JM, Vögler O, Gutiérrez A, Amat JC, Ramos R, Saus C, Ginés J, Alemany R, Diaz M, Besalduch J.
    Eur J Pharmacol; 2011 May 11; 658(2-3):57-64. PubMed ID: 21371453
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.